ClinicalTrials.Veeva

Menu

Assessing Electronic Cigarette Nicotine Flux

Virginia Commonwealth University (VCU) logo

Virginia Commonwealth University (VCU)

Status

Completed

Conditions

Electronic Cigarette Use

Treatments

Other: Cigarette Smokers/ECIG users: 6 mg/ml nicotine concentration
Other: Cigarette Smokers/ECIG users: 15 mg/ml nicotine concentration
Other: Cigarette Smoker/ECIG users: 0 mg/ml nicotine concentration
Other: Cigarette Smokers/ECIG users: 30 mg/ml nicotine concentration

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04378907
HM20018580
5U54DA036105-10 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to determine differences in nicotine delivery, use behavior, carbon monoxide delivery, subjective effects, and physiological effects, when cigarette smokers use an electronic cigarette with constant device settings and different e-liquid concentrations.

Full description

Only one arm enrolled.

Enrollment

33 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy (determined by self-report)
  • between the ages of 18-55
  • willing to provide informed consent
  • able to attend the lab and abstain from tobacco/nicotine as required and must agree to use designated products according to study protocol

Exclusion criteria

• Women if they are breast-feeding or test positive for pregnancy (by urinalysis) at screening.

Some study details about the eligibility criteria are purposely omitted at this time to preserve scientific integrity. Full details will be posted at the conclusion of the study.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

33 participants in 1 patient group

Experiemental
Experimental group
Description:
Only one arm enrolled. ECIG Lab Session, 30 watts . During each session (intervention) participants will first complete a 10-puff product use bout, and then a 90-minute product use bout.
Treatment:
Other: Cigarette Smokers/ECIG users: 30 mg/ml nicotine concentration
Other: Cigarette Smoker/ECIG users: 0 mg/ml nicotine concentration
Other: Cigarette Smokers/ECIG users: 15 mg/ml nicotine concentration
Other: Cigarette Smokers/ECIG users: 6 mg/ml nicotine concentration

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems